Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-11 4:06 pm Purchase | 13G | REZOLUTE INC RZLT | Nantahala Capital Management LLC | 4,118,164 9.9% | 4,118,164 (New Position) | View |
| 2024-02-14 4:51 pm Sale | 13G | RMR GROUP INC RMR | Nantahala Capital Management LLC | 404,063 2.6% | -554,211 (-57.83%) | View |
| 2024-02-14 4:51 pm Sale | 13G | VISTAGEN THERAPEUTICS INC VTGN | Nantahala Capital Management LLC | 1,952,368 5.1% | -845,220 (-30.21%) | View |
| 2024-02-14 4:51 pm Sale | 13G | CIDARA THERAPEUTICS INC CDTX | Nantahala Capital Management LLC | 1,546,745 1.7% | -2,820,719 (-64.58%) | View |
| 2024-02-14 4:51 pm Sale | 13G | FORTRESS BIOTECH INC FBIO | Nantahala Capital Management LLC | 372,562 4.2% | -7,595,494 (-95.32%) | View |
| 2024-02-14 4:51 pm Sale | 13G | IMAX CORPORATION IMAX | Nantahala Capital Management LLC | 2,658,753 4.9% | -2,329,436 (-46.70%) | View |
| 2024-02-14 4:51 pm Unchanged | 13G | SPYRE THERAPEUTICS, INC SYRE | Nantahala Capital Management LLC | 0 0% | 0 (Unchanged) | View |
| 2024-02-14 4:51 pm Purchase | 13G | BIOVENTUS INC BVS | Nantahala Capital Management LLC | 5,977,471 9.5% | 5,977,471 (New Position) | View |
| 2024-02-14 4:51 pm Purchase | 13G | CODEXIS INC CDXS | Nantahala Capital Management LLC | 4,592,903 6.6% | 105,121 (+2.34%) | View |
| 2024-02-14 4:51 pm Sale | 13G | DHI GROUP INC DHX | Nantahala Capital Management LLC | 2,639,687 5.6% | -1,022,289 (-27.92%) | View |
| 2024-02-14 4:51 pm Sale | 13G | LUXFER HOLDINGS PLC SHS LXFR | Nantahala Capital Management LLC | 1,809,645 6.7% | -642,674 (-26.21%) | View |
| 2024-02-14 4:51 pm Sale | 13G | RED VIOLET INC RDVT | Nantahala Capital Management LLC | 1,205,678 8.6% | -69,410 (-5.44%) | View |
| 2024-02-14 4:51 pm Sale | 13G | STRATA SKIN SCIENCES INC SSKN | Nantahala Capital Management LLC | 3,128,132 8.9% | -1,265,553 (-28.80%) | View |
| 2024-02-14 4:51 pm Sale | 13G | UNIQURE N V QURE | Nantahala Capital Management LLC | 3,158,027 6.6% | -729,912 (-18.77%) | View |
| 2024-02-14 4:51 pm Purchase | 13G | ASSERTIO HLDGS INC ASRT | Nantahala Capital Management LLC | 7,619,440 8% | 7,619,440 (New Position) | View |
| 2024-02-14 4:51 pm Purchase | 13G | EVOLUS INC EOLS | Nantahala Capital Management LLC | 2,910,849 5.1% | 2,910,849 (New Position) | View |
| 2024-02-14 4:51 pm Purchase | 13G | GAIA INC GAIA | Nantahala Capital Management LLC | 915,029 5.2% | 915,029 (New Position) | View |
| 2024-02-14 4:51 pm Purchase | 13G | NEUROONE MED TECHNOLOGIES CORP NMTC | Nantahala Capital Management LLC | 1,214,094 5.1% | 1,214,094 (New Position) | View |
| 2024-02-14 4:51 pm Purchase | 13G | NOODLES & CO NDLS | Nantahala Capital Management LLC | 3,744,571 8.3% | 3,744,571 (New Position) | View |
| 2024-02-14 4:51 pm Purchase | 13G | LYRA THERAPEUTICS INC LYRA | Nantahala Capital Management LLC | 4,752,324 8.9% | 2,531,494 (+113.99%) | View |